Navigation Links
Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
Date:1/23/2008

p>

With the addition of the autoclave, the Company believes it will own one of only approximately ten (10) permitted commercial disposal facilities in the country capable of treating all types of medical waste.

Dr. Burton J. Kunik, Chairman, President and Chief Executive Officer of the Company, commented, "We believe the purchase of this incineration facility coupled with the addition of the autoclave technology further solidifies our leadership in the industry and expands the disposal services and capabilities that we can provide to all small quantity generators of medical waste. The purchase of the Carthage facility and addition of the autoclave technology also further strengthens the vertical integration of the Company."

Sharps is also expanding its ability to dispose of unused medications and expired pharmaceutical waste including controlled substances. The Company is in the process of installing Drug Enforcement Agency (DEA) approved equipment necessary to obtain DEA certification for the disposal of controlled substances. It believes that it will be in a position to accept unused medications and expired pharmaceutical waste, including controlled substances, for destruction within the next 30 to 60 days.

The total cost of the incineration facility purchase, addition of the autoclave technology and other planned improvements at the Carthage, Texas facility is estimated to be approximately $900,000 and expected to be incurred in the third and fourth quarters of fiscal year 2008.

Dr. Kunik added, "The autoclave technology enables us to apply an environmentally cleaner and less costly alternative technology to treat medical waste. The expansion plans augment the continued build out of our operating infrastructure to ensure our long-term ability to serve prospective customers. The ability to diversify our revenue stream also expands our growth potential."

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharp
'/>"/>

SOURCE Sharps Compliance Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Genta Receives Notice of Non-Compliance With NASDAQ Rule
2. Genta Receives NASDAQ Non-Compliance Notice
3. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
4. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
5. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
6. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
7. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
8. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
9. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
10. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
11. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2010)... mechanisms critical to interactions between hot plasma and ... reactor, part of work aimed at developing coatings ... reactors. , Fusion powers the stars and could ... A fusion power plant would produce 10 times ... and because the deuterium fuel is contained in ...
(Date:7/27/2010)... point to accelerated growth in China ,s domestic market:  rising ... services, central government policy continues to urge greater consumption of goods. ... Wednesday, September 8 , executives and managers can learn how to ... , , , ... companies now figuring out how to approach the high growth market, ...
(Date:7/27/2010)... , July 27 Adeona Pharmaceuticals, Inc., ... Caudill , B.B.A., has been appointed Vice President of Finance ... 15 years of biotechnology-related accounting and Securities and Exchange Commission ... , ... in a variety of financial reporting positions at Aastrom Biosciences, ...
(Date:7/26/2010)... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) will conduct ... on Thursday, August 5, 2010 at 4:30 p.m. ... , , ... call by telephone, please dial (877) 280-7291 ( United States ) ... live and can be accessed on the "Events" page of the ...
Breaking Biology Technology:Findings show promise for nuclear fusion test reactors 2Findings show promise for nuclear fusion test reactors 3Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 2Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 3Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller 2Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller 3
... Quarter Target Agreed, GENEVA, Switzerland, February 11 ... have agreed with Molecular Vision and The Imperial ... of Molecular Vision. Following the,initial acquisition of 10.9% ... month, it has now been agreed by all ...
... on Status of Integration Planning -, SOUTH ... Sheets: VXGN), a biopharmaceutical company, and Raven,biotechnologies, inc. ... monoclonal antibody therapeutics (MAbs) for treating cancer, announced,today ... to the,proposed merger with Raven biotechnologies has been ...
... Calif., Feb. 11 Cepheid (Nasdaq:,CPHD) today announced ... as,Senior Vice President, Chief Financial Officer on April ... operations and investor,relations. Mr. Miller will report to ... Sluis, who retired from Cepheid effective,December 31, 2007., ...
Other Biology Technology:Acrongenomics on Track to Acquire Molecular Vision 2Acrongenomics on Track to Acquire Molecular Vision 3Acrongenomics on Track to Acquire Molecular Vision 4VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 2VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 3VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 4VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 5Cepheid Appoints Senior VP, Chief Financial Officer to Management Team 2
(Date:7/29/2010)... 29, 2010) Polymer strands wriggle their way through ... to there and do their jobs. New theoretical research ... journey takes. , That,s a good thing to ... and proteins -- all of which count as polymers ... in biosensors or as drug-delivery devices. , ...
(Date:7/29/2010)... black carbon to sulfate in the atmosphere increases climate ... Iowa professor and his colleagues and published in the ... . , Black carbons -- arising from such sources ... widely considered a factor in global warming and are ... according to Greg Carmichael, Karl Kammermeyer Professor of Chemical ...
(Date:7/29/2010)... Washington, D.C (July 29, 2010) While pundits write ... climate changes are already being felt across the world. ... ways that managers have never before seen. , ... these changes. In that effort, Island Press and EcoAdapt ... Climate Adaptation Knowledge Exchange (CAKE) at www.cakex.org . ...
Breaking Biology News(10 mins):Polymer passage takes time 2Study finds black carbon implicated in global warming 2CAKE offers way forward for climate change adaptation 2Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 4987 1Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 4987 2Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 1Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 2Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 3LeBow 26amp 3B Associates Moves to New Office in Manhattan 56998 1LeBow 26amp 3B Associates Moves to New Office in Manhattan 56998 2
... A team including researchers at the HudsonAlpha Institute ... number of other organizations, today publishes a comprehensive ... glioblastoma. These results are the first from the ... effort funded by the National Cancer Institute and ...
... 4, 2008) A variety of organismsfrom bacteria ... the timing and duration of fundamental biological processes is ... even under fluctuating environmental conditions. In recent years, ... basis of these rhythms and how they translate into ...
... that obesity and Type 2 Diabetes Mellitus (T2DM) can contribute ... the first study to show that obesity can cause ... Disease Volume 15:1 (September 2008) . , In ... Monte, MD, MPH, of Rhode Island Hospital, utilized chronic high ...
Other Biology News:Collaboration between researchers yields more comprehensive portrait of brain cancer 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Biology Products: